Oncopharmpod
New & Niche Drugs
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:57
- Mas informaciones
Informações:
Sinopsis
We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).
We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).
